Filter news by date News Tags - Any -News storyPress release Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year2024202320222021202020192018201720162015201420132012201120102009200820072006 Apply 8 . 25 . 2022 Press release Galderma delivers strong H1 2022 results and continued innovation across its leading dermatology portfolio 6 . 30 . 2022 Press release Galderma and Children’s Skin Disease Foundation Celebrate Decade-Long Partnership 6 . 22 . 2022 Press release Galderma announces positive data from phase III trial, demonstrating efficacy and safety of nemolizumab in patients with prurigo nodularis 6 . 10 . 2022 Press release Galderma announces positive results in two phase III studies for a novel liquid formulation botulinumtoxinA (RelabotulinumtoxinA) for the treatment of glabellar lines (frown) and lateral canthal lines (crow’s feet) 6 . 8 . 2022 Press release Galderma to present new findings from innovative product portfolio at the 2022 VCS Annual Symposium 6 . 2 . 2022 Press release Galderma Launches EPSOLAY® Cream, a Medical Advance to Treat Bumps and Blemishes of Rosacea 6 . 1 . 2022 News story Actinic Keratosis prevention campaign encourages everyone to ‘FACE THE FACTS’ 5 . 31 . 2022 Press release Galderma to present extensive new clinical data across its portfolio of neuromodulators, fillers and biostimulators at the IMCAS World Congress 2022 4 . 25 . 2022 Press release Sol-Gel Technologies and Galderma Announce FDA Approval of EPSOLAY® 4 . 6 . 2022 Press release Cetaphil® debuts global sensitive skin awareness initiative 4 . 4 . 2022 Press release Galderma launches a virtual experience this Rosacea Awareness Month showcasing how the condition goes beyond the visible with Rosacea Space 3 . 28 . 2022 Press release Galderma to present new clinical data and high patient satisfaction across their portfolio of dermal fillers, collagen biostimulators and liquid neuromodulators at AMWC 2022 Pagination Previous page Previous Page Next page Next Page